Related Concept Videos
01:22Chronic Obstructive Pulmonary Disease
1.8K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.8K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.2K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.2K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.6K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.6K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.8K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.8K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.1K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.1K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.7K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.7K
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Performance of multivariable risk prediction algorithms in predicting COPD exacerbations: a population-based study.
Thorax·2026
Same author
Standardising terminology in routine electronic health records for respiratory endpoints: why we still can't agree.
Thorax·2026
Same author
Extreme heat and cause-specific risk of hospital admission in the adult population in England: a case time series analysis.
BMJ open·2026
Same author
Accelerometer-measured postoperative physical activity confers a significant mortality benefit following joint arthroplasty.
Bone & joint research·2026
Same author
A self-controlled case series to evaluate the effects of clinical trial eligibility criteria on biologic-associated reductions in severe asthma exacerbations: an analysis of the CHRONICLE Study.
The European respiratory journal·2026
Same author
Validating exacerbations of asthma in electronic health records: a systematic review.
European respiratory review : an official journal of the European Respiratory Society·2026
Same journal
Beyond the 5th percentile: rethinking diagnostic thresholds in pulmonary function testing.
The European respiratory journal·2026
Same journal
A Transcriptomic Atlas of Chronic Lung Allograft Dysfunction.
The European respiratory journal·2026
Same journal
Risk of cancer and mortality in patients with interstitial lung diseases: Danish cohort study.
The European respiratory journal·2026
Same journal
Proposing a minimal important difference in NTproBNP in pulmonary arterial hypertension.
The European respiratory journal·2026
Same journal
Unlocking growth potential: Ivacaftor therapy and developmental gains in lung and height in a cohort study of children and young adults with cystic fibrosis.
The European respiratory journal·2026
Same journal
Decoding the Lymphangioleiomyomatosis (LAM) Niche Microenvironment <i>via</i> Integrative Analysis of Single Cell Multiomics and Spatial Transcriptomics.
The European respiratory journal·2026
Related Experiment Video
Updated: Nov 11, 2025
04:03
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
1.0K
COPD: still an unpredictable journey
1Dept of Primary Care and Public Health, Imperial College London, London, UK.
The European Respiratory Journal
|March 26, 2021
Summary
No abstract available in PubMed .
